Journal article
Chondrosarcoma of Bone
Abstract
Chondrosarcoma is the second most common malignant bone tumor and is relatively unresponsive to chemotherapy and radiation regimens. In addition, the clinical course of chondrosarcoma is difficult to predict. The purpose of this study was to review the authors' experience with chondrosarcoma and ascertain any factors related to prognosis and clinical outcome. The medical records of 108 patients followed up for a minimum of 2 years were …
Authors
Rizzo M; Ghert MA; Harrelson JM; Scully SP
Journal
Clinical Orthopaedics and Related Research®, Vol. 391, No. &NA;, pp. 224–233
Publisher
Wolters Kluwer
Publication Date
October 2001
DOI
10.1097/00003086-200110000-00025
ISSN
0009-921X